Abstract

Allostery enables dynamic control of protein function. A paradigmatic example is the tightly orchestrated process of DNA methylation maintenance. Despite the fundamental importance of allosteric sites, their identification remains highly challenging. Here we perform CRISPR scanning on the essential maintenance methylation machinery-DNMT1 and its partner UHRF1-with the activity-based inhibitor decitabine to uncover allosteric mechanisms regulating DNMT1. In contrast to non-covalent DNMT1 inhibition, activity-based selection implicates numerous regions outside the catalytic domain in DNMT1 function. Through computational analyses, we identify putative mutational hotspots in DNMT1 distal from the active site that encompass mutations spanning a multi-domain autoinhibitory interface and the uncharacterized BAH2 domain. We biochemically characterize these mutations as gain-of-function mutations that increase DNMT1 activity. Extrapolating our analysis to UHRF1, we discern putative gain-of-function mutations in multiple domains, including key residues across the autoinhibitory TTD-PBR interface. Collectively, our study highlights the utility of activity-based CRISPR scanning for nominating candidate allosteric sites, and more broadly, introduces new tools and analyses that further refine the CRISPR scanning framework.

Data availability

All data generated or analyzed during this study are included in the manuscript and supplementary files; Source Data for the CRISPR scanning experiments and individual sgRNA validation experiments are provided in Supplementary Files 1-3. The sequences of primers and oligonucleotides used in this study are provided in Supplementary File 4. Custom scripts used to analyze the data are available at https://github.com/liaulab/DNMT1_eLife_2022.

Article and author information

Author details

  1. Kevin Chun-Ho Ngan

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8067-3472
  2. Samuel M Hoenig

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  3. Hui Si Kwok

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  4. Nicholas Z Lue

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4236-9127
  5. Pallavi M Gosavi

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  6. David A Tanner

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  7. Emma M Garcia

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  8. Ceejay Lee

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  9. Brian B Liau

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    For correspondence
    liau@chemistry.harvard.edu
    Competing interests
    Brian B Liau, holds sponsored research projects with Eisai and AstraZeneca, is a scientific consultant for Imago BioSciences and Exo Therapeutics, and is a shareholder and member of the scientific advisory board of Light Horse Therapeutics..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2985-462X

Funding

National Science Foundation (Graduate Research Fellowship,DGE1745303)

  • Kevin Chun-Ho Ngan
  • Nicholas Z Lue
  • Emma M Garcia

National Institute of General Medical Sciences (New Innovator Award,1DP2GM137494)

  • Brian B Liau

Damon Runyon Cancer Research Foundation (Damon Runyon-Rachleff Innovation Award)

  • Brian B Liau

Harvard University (Landry Cancer Biology Fellowship)

  • Emma M Garcia

Harvard University (Herchel Smith Graduate Fellowship)

  • Ceejay Lee

Harvard University (Startup Funding)

  • Brian B Liau

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Ngan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,085
    views
  • 264
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kevin Chun-Ho Ngan
  2. Samuel M Hoenig
  3. Hui Si Kwok
  4. Nicholas Z Lue
  5. Pallavi M Gosavi
  6. David A Tanner
  7. Emma M Garcia
  8. Ceejay Lee
  9. Brian B Liau
(2023)
Activity-based CRISPR scanning uncovers allostery in DNA methylation maintenance machinery
eLife 12:e80640.
https://doi.org/10.7554/eLife.80640

Share this article

https://doi.org/10.7554/eLife.80640

Further reading

    1. Biochemistry and Chemical Biology
    Meina He, Yongxin Tao ... Wenli Chen
    Research Article

    Copper is an essential enzyme cofactor in bacteria, but excess copper is highly toxic. Bacteria can cope with copper stress by increasing copper resistance and initiating chemorepellent response. However, it remains unclear how bacteria coordinate chemotaxis and resistance to copper. By screening proteins that interacted with the chemotaxis kinase CheA, we identified a copper-binding repressor CsoR that interacted with CheA in Pseudomonas putida. CsoR interacted with the HPT (P1), Dimer (P3), and HATPase_c (P4) domains of CheA and inhibited CheA autophosphorylation, resulting in decreased chemotaxis. The copper-binding of CsoR weakened its interaction with CheA, which relieved the inhibition of chemotaxis by CsoR. In addition, CsoR bound to the promoter of copper-resistance genes to inhibit gene expression, and copper-binding released CsoR from the promoter, leading to increased gene expression and copper resistance. P. putida cells exhibited a chemorepellent response to copper in a CheA-dependent manner, and CsoR inhibited the chemorepellent response to copper. Besides, the CheA-CsoR interaction also existed in proteins from several other bacterial species. Our results revealed a mechanism by which bacteria coordinately regulated chemotaxis and resistance to copper by CsoR.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Jiale Zhou, Ding Zhao ... Zhanjun Li
    Research Article

    5-Methylcytosine (m5C) is one of the posttranscriptional modifications in mRNA and is involved in the pathogenesis of various diseases. However, the capacity of existing assays for accurately and comprehensively transcriptome-wide m5C mapping still needs improvement. Here, we develop a detection method named DRAM (deaminase and reader protein assisted RNA methylation analysis), in which deaminases (APOBEC1 and TadA-8e) are fused with m5C reader proteins (ALYREF and YBX1) to identify the m5C sites through deamination events neighboring the methylation sites. This antibody-free and bisulfite-free approach provides transcriptome-wide editing regions which are highly overlapped with the publicly available bisulfite-sequencing (BS-seq) datasets and allows for a more stable and comprehensive identification of the m5C loci. In addition, DRAM system even supports ultralow input RNA (10 ng). We anticipate that the DRAM system could pave the way for uncovering further biological functions of m5C modifications.